Blue Water Biotech, Inc. stock is down -41.74% since 30 days ago. The next earnings date is Mar 7, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 1 November’s closed higher than October.
Blue Water Vaccines, Inc. engages in the research and development of vaccines to prevent infectious diseases worldwide. The company's lead vaccine programs that are under preclinical development include influenza vaccine; and BWV-102, a H1 pre-pandemic vaccine.